$KFRC
KFORCE INC

2023 Q4 Form 10-Q Financial Statement

#000093042023000225 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $363.4M $373.1M
YoY Change -13.4% -14.74%
Cost Of Revenue $264.1M $269.7M
YoY Change -12.03% -13.28%
Gross Profit $99.36M $103.5M
YoY Change -16.84% -18.32%
Gross Profit Margin 27.34% 27.73%
Selling, General & Admin $76.38M $86.23M
YoY Change -19.02% -8.57%
% of Gross Profit 76.86% 83.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.236M $1.200M
YoY Change 1.9% 14.83%
% of Gross Profit 1.24% 1.16%
Operating Expenses $77.61M $87.61M
YoY Change -18.75% -8.98%
Operating Profit $21.75M $16.03M
YoY Change -9.19% -48.81%
Interest Expense $417.0K -$200.0K
YoY Change 2680.0% 2122.22%
% of Operating Profit 1.92% -1.25%
Other Income/Expense, Net -$332.0K -$181.0K
YoY Change -97.75% -80.02%
Pretax Income $21.42M $15.85M
YoY Change 132.9% -47.88%
Income Tax $5.704M $5.277M
% Of Pretax Income 26.63% 33.29%
Net Earnings $15.72M $10.58M
YoY Change 122.23% -52.5%
Net Earnings / Revenue 4.32% 2.83%
Basic Earnings Per Share $0.55
Diluted Earnings Per Share $0.82 $0.54
COMMON SHARES
Basic Shares Outstanding 19.76M shares 20.12M shares
Diluted Shares Outstanding 19.52M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.0K $100.0K
YoY Change -1.65% -98.03%
Cash & Equivalents $119.0K $122.0K
Short-Term Investments
Other Short-Term Assets $10.91M $9.500M
YoY Change 34.58% -5.18%
Inventory
Prepaid Expenses
Receivables $233.4M $248.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $244.5M $257.9M
YoY Change -11.99% -12.95%
LONG-TERM ASSETS
Property, Plant & Equipment $9.418M $9.489M
YoY Change 8.92% 45.98%
Goodwill $25.04M $25.04M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $40.39M $35.90M
YoY Change 143.03%
Other Assets $79.06M $71.78M
YoY Change 4.34% -12.21%
Total Long-Term Assets $113.5M $111.9M
YoY Change -0.63% -4.05%
TOTAL ASSETS
Total Short-Term Assets $244.5M $257.9M
Total Long-Term Assets $113.5M $111.9M
Total Assets $358.0M $369.8M
YoY Change -8.68% -10.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.80M $47.07M
YoY Change 30.64% -9.53%
Accrued Expenses $37.56M $20.18M
YoY Change 61.94% -3.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $103.0M $119.3M
YoY Change -21.65% -26.82%
LONG-TERM LIABILITIES
Long-Term Debt $41.60M $21.40M
YoY Change 62.5%
Other Long-Term Liabilities $54.32M $50.14M
YoY Change 2.94% 22.66%
Total Long-Term Liabilities $95.92M $50.14M
YoY Change 81.77% 22.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.0M $119.3M
Total Long-Term Liabilities $95.92M $50.14M
Total Liabilities $198.9M $190.8M
YoY Change -5.2% -6.4%
SHAREHOLDERS EQUITY
Retained Earnings $525.2M $516.5M
YoY Change 6.59% 5.02%
Common Stock $734.0K $732.0K
YoY Change 0.27% 0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $159.1M $179.0M
YoY Change
Total Liabilities & Shareholders Equity $358.0M $369.8M
YoY Change -8.68% -10.43%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $15.72M $10.58M
YoY Change 122.23% -52.5%
Depreciation, Depletion And Amortization $1.236M $1.200M
YoY Change 1.9% 14.83%
Cash From Operating Activities $22.37M $28.70M
YoY Change 75.52% 292.99%
INVESTING ACTIVITIES
Capital Expenditures $1.663M $1.100M
YoY Change -51.84% -191.82%
Acquisitions
YoY Change
Other Investing Activities -$599.0K -$600.0K
YoY Change -48.93% -76.0%
Cash From Investing Activities -$2.362M -$1.700M
YoY Change -48.94% -54.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.11M -26.90M
YoY Change 53.66% -5.58%
NET CHANGE
Cash From Operating Activities 22.37M 28.70M
Cash From Investing Activities -2.362M -1.700M
Cash From Financing Activities -20.11M -26.90M
Net Change In Cash -102.0K 100.0K
YoY Change -97.95% -100.4%
FREE CASH FLOW
Cash From Operating Activities $22.37M $28.70M
Capital Expenditures $1.663M $1.100M
Free Cash Flow $20.70M $27.60M
YoY Change 122.87% 224.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67744000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.38
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.31
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19158000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20022000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19317000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20206000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19518000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20450000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19621000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20634000 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1454000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1575000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
248291000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
269496000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9498000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8143000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
257911000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
277760000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9489000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8647000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71779000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75771000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5543000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4786000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
25040000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
25040000 usd
CY2023Q3 us-gaap Assets
Assets
369762000 usd
CY2022Q4 us-gaap Assets
Assets
392004000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
67253000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
72792000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
42740000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48369000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3850000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4576000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5429000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5696000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
119272000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
131433000 usd
CY2023Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
21400000 usd
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
25600000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50138000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52773000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
190810000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
209806000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73224000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73242000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
732000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
732000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
523669000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
507734000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
516540000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
492764000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
53464000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
52744000 shares
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
861989000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
819038000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
369762000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
392004000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
182198000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
16210000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4326000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
245000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
7003000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10244000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
6000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
185725000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
18574000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14341000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
187618000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10575000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5967000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
276000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
6894000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
18590000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
178952000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
188406000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19181000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4437000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
242000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
6094000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-780000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
2302000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10270000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
198205000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
26916000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4410000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
295000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
6093000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
989000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-2917000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10283000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
210533000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
22262000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4445000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
294000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q3 us-gaap Dividends Common Stock
DividendsCommonStock
5977000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22580000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
208976000 usd
us-gaap Net Income Loss
NetIncomeLoss
45359000 usd
us-gaap Net Income Loss
NetIncomeLoss
68359000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-757000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
4386000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
325000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-231000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3776000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3214000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
14602000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13293000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3111000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4313000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-750000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2737000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-675000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
167000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20880000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15571000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
289000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1989000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-4812000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
11025000 usd
kfrc Increase Decrease Supplemental Executive Retirement Plan Termination Payment
IncreaseDecreaseSupplementalExecutiveRetirementPlanTerminationPayment
0 usd
kfrc Increase Decrease Supplemental Executive Retirement Plan Termination Payment
IncreaseDecreaseSupplementalExecutiveRetirementPlanTerminationPayment
19965000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-14564000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
8659000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69056000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78063000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6076000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4656000 usd
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
5059000 usd
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
0 usd
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
765000 usd
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
750000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
500000 usd
kfrc Receivable Issued To Joint Venture
ReceivableIssuedToJointVenture
0 usd
kfrc Receivable Issued To Joint Venture
ReceivableIssuedToJointVenture
4500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2532000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9656000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
426400000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
430600000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
100000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
41470000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
42103000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
20842000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18164000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-40000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66523000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-160307000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-91900000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96989000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5089000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
19323000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
14348000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3937000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
5413000 usd
us-gaap Interest Paid Net
InterestPaidNet
623000 usd
us-gaap Interest Paid Net
InterestPaidNet
918000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3692000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
274000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
817000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
831000 usd
kfrc Stock Repurchases Incurred But Not Yet Paid
StockRepurchasesIncurredButNotYetPaid
2292000 usd
kfrc Stock Repurchases Incurred But Not Yet Paid
StockRepurchasesIncurredButNotYetPaid
1030000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:5pt"><span style="color:#004b8d;font-family:'Open Sans Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Open Sans Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most critical of these estimates and assumptions relate to the following: allowance for credit losses; income taxes; self-insured liabilities for health insurance; and the impairment of goodwill and other long-lived assets. Although these and other estimates and assumptions are based on the best available information, actual results could be materially different from these estimates. Therefore, our accounting estimates and assumptions might change materially in future periods.</span></div>
kfrc Health Insurance Stop Loss Maximum Per Claim
HealthInsuranceStopLossMaximumPerClaim
600000 usd
kfrc Health Insurance Stop Loss Maximum Per Claim
HealthInsuranceStopLossMaximumPerClaim
600000 usd
kfrc Health Insurance Aggregate Risk Of Loss Liability Amount In Excess Of The Stop Loss Maximum
HealthInsuranceAggregateRiskOfLossLiabilityAmountInExcessOfTheStopLossMaximum
280000 usd
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
360000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
304000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
428000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
428000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
95000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
186000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
304000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
301000 shares
us-gaap Operating Expenses
OperatingExpenses
288383000 usd
CY2022 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
6800000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
4800000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.01
CY2022Q3 kfrc Effective Income Tax Rate Reconciliation Excise Tax Percent Of Fmv Of Shares Repurchased
EffectiveIncomeTaxRateReconciliationExciseTaxPercentOfFMVOfSharesRepurchased
0.01
CY2023Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
200000 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
400000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
373122000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
103461000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
87609000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15852000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
437620000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
126670000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
96257000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30413000 usd
us-gaap Gross Profit
GrossProfit
327703000 usd
us-gaap Operating Expenses
OperatingExpenses
263873000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63830000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1291103000 usd
us-gaap Gross Profit
GrossProfit
381628000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
93245000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
373122000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
437620000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1168309000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1291103000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1006000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
560000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
708000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
858000 usd
CY2022Q4 kfrc Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables
AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables
600000 usd
CY2023Q3 kfrc Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables
AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables
600000 usd
CY2023Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
35881000 usd
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
31976000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14937000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17102000 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16009000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16149000 usd
CY2023Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
718000 usd
CY2022Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
881000 usd
CY2023Q3 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
0 usd
CY2022Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
4825000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4234000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4838000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71779000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75771000 usd
CY2023Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
37800000 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
36600000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
47073000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
49600000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20180000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23192000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
67253000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
72792000 usd
CY2023Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
36698000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
41506000 usd
CY2023Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1838000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2633000 usd
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3721000 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3481000 usd
CY2023Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
483000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
749000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
42740000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48369000 usd
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
37550000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
36390000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12560000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16380000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
28000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
3000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50138000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52773000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14600000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4500000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13300000 usd
CY2023Q3 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
2 derivative_instrument
CY2023Q3 kfrc Supplemental Unemployment Benefits On Change In Control
SupplementalUnemploymentBenefitsOnChangeInControl
35000000 usd
CY2023Q3 kfrc Supplemental Unemployment Benefits On No Change In Control
SupplementalUnemploymentBenefitsOnNoChangeInControl
15700000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000930420-23-000225-index-headers.html Edgar Link pending
0000930420-23-000225-index.html Edgar Link pending
0000930420-23-000225.txt Edgar Link pending
0000930420-23-000225-xbrl.zip Edgar Link pending
exhibit101kforcerestricted.htm Edgar Link pending
exhibit311q32023.htm Edgar Link pending
exhibit312q32023.htm Edgar Link pending
exhibit321q32023.htm Edgar Link pending
exhibit322q32023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0a.jpg Edgar Link pending
kfrc-20230930.htm Edgar Link pending
kfrc-20230930.xsd Edgar Link pending
kfrc-20230930_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kfrc-20230930_cal.xml Edgar Link unprocessable
kfrc-20230930_def.xml Edgar Link unprocessable
kfrc-20230930_lab.xml Edgar Link unprocessable
kfrc-20230930_pre.xml Edgar Link unprocessable
kfrc-20230930_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending